Shanghai Haohai Biological Technology (SHSC:6826) - Stock Price, News & Analysis

6826 Stock Overview

Shanghai Haohai Biological Technology Co., Ltd. More details

6826 fundamental analysis
Snowflake Score
Valuation	4/6
Future Growth	3/6
Past Performance	5/6
Financial Health	5/6
Dividends	2/6

Rewards

Trading at 79.1% below our estimate of its fair value

Earnings are forecast to grow 16.82% per year

Earnings grew by 24.5% over the past year

Risk Analysis

No risks detected for 6826 from our risk checks.

Shanghai Haohai Biological Technology Co., Ltd. Competitors

3SBio

SEHK:1530

HK$13.0b

Shanghai Henlius Biotech

SEHK:2696

HK$11.4b

Shandong Boan Biotechnology

SEHK:6955

HK$4.3b

Essex Bio-Technology

SEHK:1061

HK$1.5b

Price History & Performance

Summary of all time highs, changes and price drops for Shanghai Haohai Biological Technology
Historical stock prices
Current Share Price	HK$27.00
52 Week High	HK$42.95
52 Week Low	HK$21.71
Beta	0.76
11 Month Change	-20.35%
3 Month Change	-9.40%
1 Year Change	-14.09%
33 Year Change	-29.74%
5 Year Change	n/a
Change since IPO	-40.75%

Recent updates

Shareholder Returns

	6826	HK Biotechs	HK Market
7D	-6.9%	-0.3%	-0.6%
1Y	-14.1%	-15.2%	9.6%

Return vs Industry: 6826 exceeded the Hong Kong Biotechs industry which returned -15.2% over the past year.

Return vs Market: 6826 underperformed the Hong Kong Market which returned 9.6% over the past year.

Price Volatility

Is 6826's price volatile compared to industry and market?
6826 volatility
6826 Average Weekly Movement	7.8%
Biotechs Industry Average Movement	10.9%
Market Average Movement	8.9%
10% most volatile stocks in HK Market	19.2%
10% least volatile stocks in HK Market	4.3%

Stable Share Price: 6826 has not had significant price volatility in the past 3 months compared to the Hong Kong market.

Volatility Over Time: 6826's weekly volatility (8%) has been stable over the past year.

About the Company

Founded	Employees	CEO	Website
2007	2,179	Jianying Wu	www.3healthcare.com

Shanghai Haohai Biological Technology Co., Ltd. engages in the research, development, manufacture, and sale of biomedical materials in China, Europe, the United States, and internationally. The company offers ophthalmology products consisting intraocular lens, medical sodium hyaluronate gel, and lubricant eye drop.

Shanghai Haohai Biological Technology Co., Ltd. Fundamentals Summary

How do Shanghai Haohai Biological Technology's earnings and revenue compare to its market cap?
6826 fundamental statistics
Market cap	HK$13.90b
Earnings (TTM)	HK$462.20m
Revenue (TTM)	HK$2.95b

13.5x

P/E Ratio

2.1x

P/S Ratio

Is 6826 overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
6826 income statement (TTM)
Revenue	CN¥2.75b
Cost of Revenue	CN¥848.86m
Gross Profit	CN¥1.90b
Other Expenses	CN¥1.47b
Earnings	CN¥430.21m

Last Reported Earnings

Sep 30, 2024

Next Earnings Date

n/a

Earnings per share (EPS)	1.87
Gross Margin	69.10%
Net Profit Margin	15.66%
Debt/Equity Ratio	7.0%

How did 6826 perform over the long term?

See historical performance and comparison

Dividends

3.2%

Current Dividend Yield

85%

Payout Ratio

Shanghai Haohai Biological Technology SHSC:6826 Stock Report